Latest News

Latest News

News from the World Hepatitis Alliance

HIV patients with viral hepatitis are three times more likely to have liver disease, liver failure and liver-related deaths

1 Dec 2015 Bridie Taylor

On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2015 -...

Innovative patent agreement shows success of patient advocacy

23 Nov 2015 Bridie Taylor

The World Hepatitis Alliance congratulates the Medicines Patent Pool (MPP) and Bristol – Myers Squibb (BMS) for recognising the global hepatitis...

Medicines Patent Pool expands its mandate to hepatitis C treatment

6 Nov 2015 Bridie Taylor

The World Hepatitis Alliance welcomes the recent announcement from the Medicines Patent Pool (MPP) that they will be expanding their mandate to...

The global hepatitis community unites to demand access to life-saving hepatitis treatment

2 Nov 2015 Bridie Taylor

London, 2 November 2015: Today the World Hepatitis Alliance launches an open letter calling for immediate action to vastly improve access to life-...

Webinar on the Global Movement to Eliminate Viral Hepatitis

27 Oct 2015 Bridie Taylor

Learn more about the global movement to eliminate viral hepatitis. On 28 th October WHA President Charles Gore and WHA Executive Board Member for the...

WHO Regional Committee meetings see regions commit to tackling viral hepatitis

23 Oct 2015 Bridie Taylor

Despite viral hepatitis impacting almost every country in the world, the burden differs significantly from region to region. In order to achieve...

Expanding the membership base of the World Hepatitis Alliance

1 Oct 2015 Bridie Taylor

The membership base of the World Hepatitis Alliance continues to go from strength to strength as we welcome five new organisations. Our membership is...

Looking ahead to the next Summit

17 Sep 2015 Bridie Taylor

Following the first World Hepatitis Summit that took place in Glasgow, Scotland 2-4 September, we are already looking ahead to the next Summit. The...

Cost of comprehensive global viral hepatitis prevention and treatment effort might peak at $11 billion in 2025

15 Sep 2015

By Keith Alcorn, Infohep.org Reaching the World Health Organization’s proposed targets for viral hepatitis control by 2030 could require global...

Medicines Patent Pool looks at hepatitis C

14 Sep 2015

By Keith Alcorn, Infohep.org Greg Perry, Executive Director of the Medicines Patent Pool, told delegates at the World Hepatitis Summit in Glasgow...

World Health Organization calls for ambitious global targets for viral hepatitis control

5 Sep 2015

By Keith Alcorn, Infohep.org The World Health Organization (WHO) is calling for ambitious new global targets for diagnosis, treatment and cure of...

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit

4 Sep 2015 Bridie Taylor

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit Global leaders...

World Hepatitis Summit: New data shows relentless rise in hepatitis deaths

2 Sep 2015

New data shows relentless rise in hepatitis deaths: World leaders meet in Scotland to discuss urgent response and move towards elimination of 7th...

Is the elimination of viral hepatitis on the horizon?

28 Jul 2015 Bridie Taylor

Today marks the fifth official World Hepatitis Day where members of the public and the hepatitis community provide a voice for the 4000 lives lost...

Welcoming new members to the World Hepatitis Alliance

17 Jul 2015 Bridie Taylor

Over the past few months we have welcomed a surge of new members to the World Hepatitis Alliance and we are proud to now have 216 member groups in 80...

2 weeks until World Hepatitis Day!

14 Jul 2015 Bridie Taylor

July 28 is now fast approaching and it’s set to be the biggest World Hepatitis Day yet! But we need your support to ensure we reach as many people as...

Calling for greater commitment to the fight against hepatitis at the World Health Assembly

28 May 2015 Bridie Taylor

The 68th session of the World Health Assembly (WHA68) took place in Geneva from 18th-26th May. On 25th May, the World Hepatitis Alliance was invited...

Working closely with WHO to develop a global strategy

1 Apr 2015 Bridie Taylor

WHO Strategic and Technical Advisory Committee for hepatitis (STAC-HEP) meeting, Geneva, Switzerland, 19 – 20 February As part of an expert advisory...

Supporting the launch of guidelines and policies to address viral hepatitis

1 Apr 2015 Bridie Taylor

WHO Injection Safety policy Every year 1.7 million people are infected with hepatitis B through unsafe injection and 315,000 with hepatitis C. Yet up...

Highlighting the importance of patient advocacy at international conferences

31 Mar 2015 Bridie Taylor

24th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Istanbul, Turkey, 12 – 15 March Patient led advocacy is vital in...

Pages

News from infohep

HIV infection is a risk factor for liver fat accumulation

13 Aug 2018 Liz Highleyman
People living with HIV are about twice as likely to develop steatosis, or fat accumulation in the liver, even if they don't have hepatitis B or...

Supervised drug consumption sites offer opportunities for HCV testing and treatment

2 Aug 2018 Liz Highleyman
Most supervised drug consumption facilities offer hepatitis C virus (HCV) testing and referrals, but very few offer treatment, indicating that they...

Treat all with hepatitis C, World Health Organization recommends

30 Jul 2018 Keith Alcorn
Everyone with hepatitis C should receive treatment with a pan-genotypic regimen, the World Health Organization recommends in new guidelines issued in...

Unprecedented hepatitis C infection rates seen in gay men in Amsterdam PrEP programme

30 Jul 2018 Gus Cairns
Regular hepatitis C testing among the HIV-negative gay men and other men who have sex with men (MSM) participating in the Amsterdam pre-exposure...

DAA therapy for HCV patients without serious liver disease has significant survival benefits

26 Jul 2018 Michael Carter
Successful HCV treatment with direct-acting antivirals (DAAs) significantly reduces the risk of death for people who do not have advanced liver...

People with mental health and substance use issues still less likely to receive HCV therapy

24 Jul 2018 Michael Carter
The proportion of people with chronic hepatitis C virus (HCV) infection who receive antiviral treatment has increased substantially since the...

Advent of DAAs accompanied by dramatic improvement in survival after HCV-related liver transplant

18 Jul 2018 Michael Carter
Survival among people with hepatitis C virus (HCV) undergoing liver transplant has improved significantly since the introduction of direct-acting...

Ramucirumab targeted therapy extends liver cancer survival

9 Jul 2018 Liz Highleyman
Ramucirumab (Cyramza), a type of targeted therapy that slows tumour growth by blocking blood vessel formation, led to improved overall survival and...

New simplified scoring system identifies people with hepatitis B in need of treatment in Africa

2 Jul 2018 Keith Alcorn
Liver enzyme and hepatitis B 'e' antigen test results are sufficient to determine which people with hepatitis B need antiviral treatment...

Mixed results for experimental therapies for NASH

22 Jun 2018 Liz Highleyman
The recent International Liver Congress in Paris featured several presentations on investigational therapies for fatty liver disease. Drugs with a...